Physician profile
Matthew D Neuhaus
NPI 1346239498
$33,261.75
in general payments reported to CMS, 2019-2025
26 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.19 · 2020: $51.57 · 2021: $665 · 2022: $594 · 2023: $475 · 2024: $921 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $30K · Food and Beverage: $1,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $30,000.00 |
| Food and Beverage | $1,858.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $30,170.10 | 2023-2025 | |
| Organogenesis INC. | $799.36 | 2021-2024 | Puraply Wound Matrix, Puraply |
| Smith+Nephew, INC. | $632.08 | 2020-2025 | Grafix, Grafix Pl |
| Abbvie INC. | $406.23 | 2021-2025 | |
| Abbott Laboratories | $176.88 | 2024 | Proclaim, Eterna, Octrode |
| Stryker Corporation | $162.08 | 2021-2024 | Claw II, Phalinx, Variax |
| Highridge Medical LLC | $96.92 | 2024 | Biomet Ebi Bone Healing System |
| Nevro Corp. | $90.82 | 2022-2024 | Senza |
| Alpha Orthopedic Systems | $89.33 | 2021-2022 | |
| Horizon Therapeutics Plc | $84.94 | 2019-2022 | |
| Treace Medical Concepts, INC. | $84.73 | 2025 | |
| Paratek Pharmaceuticals, INC. | $74.42 | 2020-2025 | Nuzyra |
| Lifenet Health | $74.07 | 2025 | Theragenesis Wound Matrix |
| Grt US Holding, INC. | $50.65 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $49.05 | 2025 | Purified Cortrophin Gel |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $35.82 | 2019 | |
| Medtronic, INC. | $25.69 | 2023 | Intellis Adaptivestim |
| Triad Life Sciences INC. | $24.83 | 2022 | |
| Djo, LLC | $24.83 | 2024 | Cmf |
| Integra Lifesciences Corporation | $22.23 | 2022 | |
| Paragon 28, INC. | $18.16 | 2021 | |
| Melinta Therapeutics, LLC | $14.89 | 2021 | |
| Alfasigma USA, INC. | $14.46 | 2021 | |
| Bioventus LLC | $14.18 | 2024 | Exogen Ultrasound Bone Healing System |
| Reprise Biomedical, INC. | $12.94 | 2024 | Miro3d |
| Merck Sharp & Dohme LLC | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Neuhaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.